ArticleRSC advances2026
Comparative binding and activity analysis of known serine hydroxymethyltransferase inhibitors in biochemical assays.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Serine hydroxymethyltransferase (SHMT) is a crucial enzyme in folate metabolism, transferring a methylene group from serine to tetrahydrofolate (THF). It plays a key role in one-carbon metabolism, particularly in purine and thymidine biosynthesis, which has been linked to various cancers. Recently, a small number of small-molecule inhibitors distinct from traditional antifolates have been identified, such as SHIN1, SHIN2, AGF347 and W478. However, comprehensive cell-free biochemical data for binding and activity analysis of these inhibitors are lacking. By using thoroughly characterized recombinant SHMT1/2, this study investigates direct inhibitor binding by protein thermal shift assay and aims to expand the use of a known biochemical coupled enzyme approach, which has not yet been applied to determine the inhibitory activity of chemical test compounds, to evaluate the activity of these inhibitors against SHMT1 and SHMT2. Our work provides a comprehensive analysis of nine different SHMT1/2 inhibitors, thereby presenting a new methodological strategy that fills a gap in the existing literature on SHMT inhibition as well as opening up new avenues for the development and investigation of SHMT1/2 inhibitors.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.